Literature DB >> 33859790

Thienopyridinyl and Thiazolopyridinyl Compounds as IRAK4 Inhibitors.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33859790      PMCID： PMC8040031          DOI： 10.1021/acsmedchemlett.1c00147

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors.

Authors:  Jiamin Zheng; Jun Wu; Xiao Ding; Hong C Shen; Ge Zou
Journal:  Bioorg Med Chem Lett       Date:  2021-02-18       Impact factor: 2.823

Review 2.  IRAK family in inflammatory autoimmune diseases.

Authors:  Lin-Chong Su; Wang-Dong Xu; An-Fang Huang
Journal:  Autoimmun Rev       Date:  2020-01-07       Impact factor: 9.754

Review 3.  Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.

Authors:  Mahesh Chandra Patra; Masaud Shah; Sangdun Choi
Journal:  Semin Cancer Biol       Date:  2019-05-02       Impact factor: 15.707

Review 4.  Toll-like Receptors and the Control of Immunity.

Authors:  Katherine A Fitzgerald; Jonathan C Kagan
Journal:  Cell       Date:  2020-03-11       Impact factor: 66.850

Review 5.  Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury.

Authors:  Sarah A Robertson; Mark R Hutchinson; Kenner C Rice; Peck-Yin Chin; Lachlan M Moldenhauer; Michael J Stark; David M Olson; Jeffrey A Keelan
Journal:  Clin Transl Immunology       Date:  2020-04-14

Review 6.  Functional diversity of cancer-associated fibroblasts in modulating drug resistance.

Authors:  Luke Bu; Hideo Baba; Tadahito Yasuda; Tomoyuki Uchihara; Takatsugu Ishimoto
Journal:  Cancer Sci       Date:  2020-08-11       Impact factor: 6.716
  6 in total
  1 in total

1.  Graph Embedding Based Novel Gene Discovery Associated With Diabetes Mellitus.

Authors:  Jianzong Du; Dongdong Lin; Ruan Yuan; Xiaopei Chen; Xiaoli Liu; Jing Yan
Journal:  Front Genet       Date:  2021-11-25       Impact factor: 4.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.